1,197
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Hydroxysafflor yellow A reduces myocardial infarction size after coronary artery ligation in rats

, , , , &
Pages 458-462 | Received 23 Jan 2008, Accepted 04 Mar 2008, Published online: 01 May 2009
 

Abstract

This study was undertaken to determine the cardioprotective effect of hydroxysafflor yellow A (HSYA), at doses of 2, 4 or 8 mg/kg, extracted from the flower of the safflower plant, Carthamus tinctorius L. (Asteraceae), on acute myocardial ischemia induced by left anterior descending coronary artery (LAD) ligation in rats. The myocardial infarction size (MIS), creatine kinase (CK-MB) activity, endothelial nitric oxide synthase (eNOS) activity, superoxide dismutase (SOD) activity, malondialdehyde (MDA) content and nitric oxide (NO) content were measured. The results showed that administration with hydroxysafflor yellow A at doses of 4 or 8 mg/kg resulted in a reduction in myocardial infarction size. Hydroxysafflor yellow A (4 or 8 mg/kg) inhibited not only the elevation of creatine kinase activity and malondialdehyde content but also the reduction of superoxide dismutase activity, endothelial nitric oxide synthase activity and nitric oxide content. The findings suggested that hydroxysafflor yellow A (4 or 8 mg/kg) exerted cardioprotective effects against acute myocardial ischemic injury by regulating superoxide dismutase activity and endothelial nitric oxide synthase activity.

Acknowledgements

This study was supported by the National High Technology Research and Development Program of China (No. 2002AA283139), the Young Scientist Foundation of Yantai University, and Shandong Luye Pharmaceutical Limited Company.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.